Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
01-Apr-2025 | 885 | 928.7 | 880.8 | 917 | 28,706 | 21,23,70,722.1 | 84,535 |
02-Apr-2025 | 912.8 | 923.85 | 895 | 909.65 | 16,978 | 11,35,20,306.8 | 65,792 |
03-Apr-2025 | 910.15 | 995 | 910.15 | 970.55 | 1,06,931 | 1,93,84,53,314.3 | 2,16,920 |
04-Apr-2025 | 974.7 | 974.7 | 910.7 | 929.2 | 29,760 | 37,69,11,125.1 | 1,43,455 |
07-Apr-2025 | 802 | 890.5 | 802 | 883.35 | 22,912 | 16,09,27,184.6 | 74,491 |
08-Apr-2025 | 898.95 | 904.4 | 876.45 | 880.8 | 15,868 | 8,75,42,109.7 | 34,968 |
09-Apr-2025 | 865 | 888.35 | 823.85 | 828.1 | 20,286 | 19,19,02,650.6 | 1,16,369 |
11-Apr-2025 | 863 | 939.85 | 842.6 | 918.3 | 94,198 | 1,30,35,14,383.2 | 1,49,044 |
15-Apr-2025 | 902.35 | 925.3 | 892.1 | 919.9 | 30,490 | 41,00,31,829.8 | 86,216 |
16-Apr-2025 | 927.8 | 927.8 | 907.5 | 915.95 | 13,780 | 8,07,30,157.85 | 40,475 |
17-Apr-2025 | 921 | 924.8 | 895.2 | 918.95 | 14,727 | 23,08,98,383.45 | 1,46,438 |
21-Apr-2025 | 922.95 | 926.7 | 906.05 | 915.95 | 21,342 | 20,87,87,605 | 74,907 |
22-Apr-2025 | 920 | 925.5 | 905.25 | 917.25 | 15,441 | 11,17,22,854.25 | 42,861 |
23-Apr-2025 | 922 | 935 | 912.4 | 923.85 | 16,211 | 13,10,46,165.2 | 69,004 |
24-Apr-2025 | 935 | 967.95 | 919.6 | 952.65 | 57,411 | 65,22,50,051.75 | 2,56,267 |
25-Apr-2025 | 958 | 962 | 901 | 910 | 37,997 | 39,82,23,832.75 | 1,15,905 |
28-Apr-2025 | 911.9 | 916.8 | 897.55 | 907.4 | 12,434 | 12,12,29,415.55 | 64,548 |
29-Apr-2025 | 909 | 918.85 | 880 | 894.7 | 13,170 | 10,26,46,453.7 | 51,636 |
This FDA audit confirms compliance with regulatory standards, enhancing the credibility of Jubilant's operations in the United States.
Jubilant Pharmova Ltd has gained a total of 126% in the last one year, and almost 75% gain since the beginning of the year.
Here are some of the stocks that may see significant price movement today: Tata Motors, Reliance Industries, IREDA, etc.
Drug company Jubilant Pharmova Ltd will acquire an 80% stake in Pierre Fabre Laboratories' Research & Development Centre in Saint Julien, France.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
